OIS San Diego

MAY 2, 2019
SAN DIEGO, CA

OIS unites over 500 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@ASCRS
OIS Chicago

JULY 25, 2019
CHICAGO, IL

OIS unites 300 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@ASRS 2019
OIS San Francisco

OCTOBER 10, 2019
SAN FRANCISCO, CA

OIS unites over 1,000 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@AAO

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

FDA Forum Sounds Call for OCT Standards

Takeaway from FDA Imaging Forum: Need for Consensus Standards for Optical Coherence Tomography

Continued advances in optical coherence tomography are generating excitement for more precise and earlier diagnosis of eye disease, but more research and industry agreement on ...
Will Dexycu’s Cost Inhibit Its Use?

Will Dexycu’s Cost Inhibit Its Use?

Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island, recently performed the first cataract surgery in the country using Dexycu (EyePoint Pharmaceuticals), administered as a ...
OIS Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

The OIS Index of ophthalmic stocks solidly outperformed its market benchmarks in the first quarter of 2019, gaining 37.1%. During Q1, the overall US stock ...
Dr. Mark Blumenkranz Previews Panel on OCT Imaging and Forum on Laser-Based Imaging

Dr. Mark Blumenkranz Previews Panel on OCT Imaging and Forum on Laser-Based Imaging

Regulatory and reimbursement issues surrounding laser-based imaging modalities such as optical coherence tomography and adaptive optics, as well as the emerging role of artificial intelligence ...
Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?

Will a New Drug Using Cannabinoids Achieve a Breakthrough for Glaucoma?

SAN FRANCISCO – Nemus Bioscience, a biopharmaceutical company based in Southern California, came to the Glaucoma 360 New Horizons Forum here in February to make ...
Biogen Jumps Back into Ophthalmology Gene Therapy with Nightstar Acquisition

Biogen Jumps Back into Ophthalmology Gene Therapy with Nightstar Acquisition

It didn’t take Biogen long to jump back into ophthalmology after announcing its intention in December 2018 to terminate a collaborative agreement with Applied Genetic ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.